Cardiol Therapeutics Cash Flow Statement (2020-2026) | CRDL

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-5.20M-8.05M-10.57M-7.67M-7.09M-9.84M-6.38M-5.96M-5.70M-6.93M
Depreciation and Depletion (Quarter)
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.02M0.03M0.02M0.02M0.02M0.02M0.02M
Share-based Compensation (Quarter)
0.67M0.75M3.64M0.84M-0.46M2.75M0.70M0.32M0.50M1.53M0.74M0.67M1.32M6.17M2.25M0.80M1.83M2.91M2.16M1.34M
Gains from Investment Securities (Quarter)
-1.10M1.42M2.46M-0.00M-0.63M0.72M-0.36M-0.11M
Cash from Restructuring (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Cash from Operations (Quarter)
-4.94M-5.07M-3.17M-8.22M-2.01M-1.30M-9.24M-7.36M-3.99M-2.55M-4.75M-5.14M-3.49M-5.70M-4.00M-4.99M-3.28M-5.03M-3.75M-5.48M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.12M
Depreciation & Amortization (CF) (Quarter)
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.02M0.03M0.02M0.02M0.02M0.02M0.02M
Change in Working Capital
Change in Receivables (Quarter)
-0.06M0.03M0.00M-0.02M-0.03M-0.02M-0.04M0.01M0.01M0.01M0.03M-0.01M0.04M0.03M-0.03M0.02M0.01M0.02M-0.01M-0.01M
Change in Inventory (Quarter)
Change in Account Payables (Quarter)
0.13M-0.28M1.86M0.57M1.62M0.00M1.24M-1.93M0.33M0.02M0.62M0.60M0.42M-2.30M0.49M0.52M0.20M2.00M-2.51M1.23M
Change in Accured Expenses (Quarter)
-1.68M-0.68M-1.32M-0.05M0.64M-0.29M1.34M-0.51M-0.99M1.12M
Other Working Capital Changes (Quarter)
-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.00M-0.01M-0.01M-0.01M-0.01M
Investing Activities
Capital Expenditures (Quarter)
0.01M0.02M-0.01M-0.00M-0.01M0.07M-0.03M-0.00M-0.00M0.09M-0.00M-0.00M-0.01M0.03M-0.01M-0.00M-0.00M0.03M-0.03M
Cash from Investing Activities (Quarter)
0.01M-0.01M-0.00M-0.01M-0.04M-0.03M-0.00M-0.00M-0.01M-0.00M-0.00M-0.01M-0.00M-0.01M-0.00M-0.00M-0.00M-0.03M
Financing Activities
Other financing activities (Quarter)
0.08M0.10M0.07M0.06M-0.90M
Change in Capital Stock
Shares Issued (Quarter)
69.58M71.36M113.38M112.94M112.27M112.66M108.70M110.23M109.09M125.86M128.38M130.70M-149.62M-152.79M-163.26M
Net Equity Issued and Repurchased (Quarter)
49.25M10.83M
Misc.
Cash from Financing Activities (Quarter)
16.91M1.85M47.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M0.06M0.06M-0.00M13.38M-0.01M0.01M-0.01M11.15M9.92M
Exchange Rate Effect (Quarter)
1.10M-1.42M-2.46M0.00M0.63M-0.72M0.36M0.11M-0.26M-0.08M-0.40M0.27M0.16M
Change in Cash (Quarter)
11.97M-3.23M43.84M-8.24M-2.03M-1.32M-9.29M-7.40M-4.00M-2.56M-4.77M-5.08M-3.44M-5.70M9.37M-5.00M-3.27M-5.04M7.40M4.40M
Beginning Cash Balance (Quarter)
66.24M43.99M25.92M21.31M15.62M
Free Cash Flow (Quarter)
-4.94M-5.08M-3.19M-8.21M-2.01M-1.29M-9.32M-7.32M-3.98M-2.54M-4.84M-5.13M-3.49M-5.69M-4.03M-4.98M-3.28M-5.03M-3.78M-5.45M
Net Cash Flow (Quarter)
11.97M-3.21M43.84M-8.24M-2.03M-1.32M-9.29M-7.40M-4.00M-2.56M-4.77M-5.08M-3.44M-5.70M9.37M-5.00M-3.27M-5.04M7.40M4.40M